Johnson & Johnson Financial Statements (JNJ)
|
|
|
|
Report date
|
|
|
22.02.2021 |
17.02.2022 |
31.12.2022 |
16.02.2023 |
16.02.2024 |
|
23.10.2024 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
82 584 |
78 740 |
94 943 |
79 990 |
85 159 |
|
88 772 |
|
Operating Income, bln rub |
|
|
16 945 |
20 470 |
23 703 |
23 193 |
23 409 |
|
22 287 |
|
EBITDA, bln rub |
? |
|
27 498 |
30 925 |
21 939 |
27 170 |
23 725 |
|
31 579 |
|
Net profit, bln rub |
? |
|
14 714 |
20 878 |
17 941 |
17 941 |
35 153 |
|
13 329 |
|
|
OCF, bln rub |
? |
|
23 536 |
23 410 |
21 194 |
21 194 |
22 791 |
|
17 283 |
|
CAPEX, bln rub |
? |
|
3 347 |
3 652 |
4 009 |
4 009 |
4 543 |
|
4 062 |
|
FCF, bln rub |
? |
|
20 189 |
19 758 |
17 185 |
17 185 |
18 248 |
|
13 221 |
|
Dividend payout, bln rub
|
|
|
10 481 |
11 032 |
11 682 |
11 682 |
11 770 |
|
8 839 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
71.2% |
52.8% |
65.1% |
65.1% |
33.5% |
|
66.3% |
|
|
OPEX, bln rub |
|
|
34 424 |
34 395 |
40 151 |
33 181 |
58 606 |
|
38 374 |
|
Cost of production, bln rub |
|
|
28 427 |
23 402 |
31 089 |
24 596 |
26 553 |
|
27 126 |
|
R&D, bln rub |
|
|
12 340 |
14 277 |
15 386 |
14 135 |
15 085 |
|
16 886 |
|
Interest expenses, bln rub |
|
|
201.0 |
183.0 |
214.0 |
276.0 |
772.0 |
|
618.0 |
|
|
Assets, bln rub |
|
|
174 894 |
182 018 |
187 378 |
187 378 |
167 558 |
|
178 287 |
|
Net Assets, bln rub |
? |
|
63 278 |
74 023 |
76 804 |
76 804 |
68 774 |
|
70 158 |
|
Debt, bln rub |
|
|
35 266 |
33 751 |
39 659 |
39 642 |
29 332 |
|
35 751 |
|
Cash, bln rub |
|
|
25 185 |
31 608 |
23 519 |
22 281 |
22 927 |
|
20 297 |
|
Net debt, bln rub |
|
|
10 081 |
2 143 |
16 140 |
17 361 |
6 405 |
|
15 454 |
|
|
Ordinary share price, rub |
|
|
157.4 |
171.1 |
176.7 |
176.7 |
156.7 |
|
150.2 |
|
Number of ordinary shares, mln |
|
|
2 633 |
2 629 |
2 632 |
2 614 |
2 534 |
|
2 427 |
|
|
Market cap, bln rub |
|
|
414 305 |
449 737 |
464 960 |
461 692 |
397 101 |
|
364 564 |
|
EV, bln rub |
? |
|
424 386 |
451 880 |
481 100 |
479 053 |
403 506 |
|
380 018 |
|
Book value, bln rub |
|
|
-26 517 |
-7 615 |
-16 752 |
2 268 |
-1 959 |
|
-14 131 |
|
|
EPS, rub |
? |
|
5.59 |
7.94 |
6.82 |
6.86 |
13.9 |
|
5.49 |
|
FCF/share, rub |
|
|
7.67 |
7.52 |
6.53 |
6.58 |
7.20 |
|
5.45 |
|
BV/share, rub |
|
|
-10.1 |
-2.90 |
-6.36 |
0.87 |
-0.77 |
|
-5.82 |
|
|
EBITDA margin, % |
? |
|
33.3% |
39.3% |
23.1% |
34.0% |
27.9% |
|
35.6% |
|
Net margin, % |
? |
|
17.8% |
26.5% |
18.9% |
22.4% |
41.3% |
|
15.0% |
|
FCF yield, % |
? |
|
4.87% |
4.39% |
3.70% |
3.72% |
4.60% |
|
3.63% |
|
ROE, % |
? |
|
23.3% |
28.2% |
23.4% |
23.4% |
51.1% |
|
19.0% |
|
ROA, % |
? |
|
8.41% |
11.5% |
9.57% |
9.57% |
21.0% |
|
7.48% |
|
|
P/E |
? |
|
28.2 |
21.5 |
25.9 |
25.7 |
11.3 |
|
27.4 |
|
P/FCF |
|
|
20.5 |
22.8 |
27.1 |
26.9 |
21.8 |
|
27.6 |
|
P/S |
? |
|
5.02 |
5.71 |
4.90 |
5.77 |
4.66 |
|
4.11 |
|
P/BV |
? |
|
-15.6 |
-59.1 |
-27.8 |
203.6 |
-202.7 |
|
-25.8 |
|
EV/EBITDA |
? |
|
15.4 |
14.6 |
21.9 |
17.6 |
17.0 |
|
12.0 |
|
Debt/EBITDA |
|
|
0.37 |
0.07 |
0.74 |
0.64 |
0.27 |
|
0.49 |
|
|
R&D/CAPEX, % |
|
|
368.7% |
390.9% |
383.8% |
352.6% |
332.0% |
|
415.7% |
|
|
CAPEX/Revenue, % |
|
|
4.05% |
4.64% |
4.22% |
5.01% |
5.33% |
|
4.58% |
|
| Johnson & Johnson shareholders |
